TheraRadar
← Back
Data updated: Mar 29, 2026

XGEN PHARMS

OncologyInfectious Disease
Generics

XGEN PHARMS is a generic drug manufacturer focused on Oncology, Infectious Disease.

1992
Since
17
Drugs
-
Trials
155
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

TRANEXAMIC ACID 2026-01-26
LEVETIRACETAM 2025-12-02
LEVETIRACETAM 2025-11-21
NELARABINE 2025-11-06
Labeling
DEHYDRATED ALCOHOL 2025-10-23
Type 5 - New Formulation or New Manufacturer
TRANEXAMIC ACID 2025-08-20
Labeling
TRANEXAMIC ACID 2025-08-19
LEVETIRACETAM 2025-08-15
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 75%
3 drugs
Infectious Disease 25%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Infectious Disease
Merck big-pharma
Oncology, Infectious Disease
Baxter specialty
Infectious Disease, Oncology
AbbVie big-pharma
Oncology, Infectious Disease
Johnson & Johnson big-pharma
Oncology, Infectious Disease